These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36622889)

  • 21. Spotlight on adapalene in acne vulgaris.
    Waugh J; Noble S; Scott LJ
    Am J Clin Dermatol; 2004; 5(5):369-71. PubMed ID: 15554742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies.
    Eichenfield LF; Jarratt M; Schlessinger J; Kempers S; Manna V; Hwa J; Liu Y; Graeber M;
    J Drugs Dermatol; 2010 Jun; 9(6):639-46. PubMed ID: 20645525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trifarotene (Aklief) - a new topical retinoid for acne.
    Med Lett Drugs Ther; 2019 Dec; 61(1587):195-197. PubMed ID: 31999666
    [No Abstract]   [Full Text] [Related]  

  • 24. Tazarotene Lotion 0.045% for the Treatment of Acne.
    Zip C
    Skin Therapy Lett; 2022 Jul; 27(4):1-3. PubMed ID: 35857858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trial.
    Leyden J; Lowe N; Kakita L; Draelos Z
    Cutis; 2001 Jun; 67(6 Suppl):10-6. PubMed ID: 11499327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
    Maiti R; Sirka CS; Ashique Rahman MA; Srinivasan A; Parida S; Hota D
    Clin Drug Investig; 2017 Nov; 37(11):1083-1091. PubMed ID: 28913735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations.
    Greenspan A; Loesche C; Vendetti N; Georgeian K; Gilbert R; Poncet M; Baker MD; Soto P
    Cutis; 2003 Jul; 72(1):76-81. PubMed ID: 12889719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of topical tazarotene in the treatment of mild to moderate acne.
    Leyden JJ
    Cutis; 2004 Oct; 74(4 Suppl):9-15. PubMed ID: 15543714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the tolerability of adapalene 0.1% cream and adapalene 0.1% lotion in healthy individuals.
    Herndon JH; Stephens TJ; Trookman NS; Rizer RL; Preston N; Caveney S; Gottschalk RW
    Skinmed; 2012; 10(3):136-42. PubMed ID: 22779096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment.
    Leyden JJ; Shalita A; Thiboutot D; Washenik K; Webster G
    Clin Ther; 2005 Feb; 27(2):216-24. PubMed ID: 15811485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adapalene 0.1% and benzoyl peroxide 2.5% as a fixed-dose combination gel is as well tolerated as the individual components alone in terms of cumulative irritancy.
    Loesche C; Pernin C; Poncet M
    Eur J Dermatol; 2008; 18(5):524-6. PubMed ID: 18693154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tazarotene 0.045% Lotion for Females With Acne: Analysis of Two Adult Age Groups.
    Stein Gold L; Kircik L; Baldwin H; Callender V; Tanghetti E; Del Rosso J; Zeichner J; Cook-Bolden F; Guenin E
    J Drugs Dermatol; 2022 Jun; 21(6):587-595. PubMed ID: 35674760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cumulative irritation potential of topical retinoid formulations.
    Leyden JJ; Grossman R; Nighland M
    J Drugs Dermatol; 2008 Aug; 7(8 Suppl):s14-8. PubMed ID: 18724650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.
    Capizzi R; Landi F; Milani M; Amerio P
    Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin.
    Tanghetti EA; Zeichner JA; Gold M; Sadick N; Cook-Bolden FE; Kircik LH; Stein Gold L; Weiss J; Tyring SK; Del Rosso JQ; Guenin E
    J Dermatolog Treat; 2023 Dec; 34(1):2147391. PubMed ID: 36382987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris.
    Cunliffe WJ; Danby FW; Dunlap F; Gold MH; Gratton D; Greenspan A
    Eur J Dermatol; 2002; 12(4):350-4. PubMed ID: 12095880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical retinoids in acne--an evidence-based overview.
    Thielitz A; Abdel-Naser MB; Fluhr JW; Zouboulis CC; Gollnick H
    J Dtsch Dermatol Ges; 2008 Dec; 6(12):1023-31. PubMed ID: 18479477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Polymeric Lotion Formulation of Once-Daily Tazarotene (0.045%) for Moderate-to-Severe Acne: Pooled Phase 3 Analysis.
    Tanghetti EA; Werschler WP; Lain E; Guenin E; Harris S; Loncaric A; Pillai R
    J Drugs Dermatol; 2020 Mar; 19(3):272-279. PubMed ID: 32549090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Halobetasol 0.01%/Tazarotene 0.045% Fixed-combination Lotion in the Treatment of Plaque Psoriasis: Sensitization and Irritation Potential.
    Del Rosso JQ; Kircik L; Lin T; Pillai R
    J Clin Aesthet Dermatol; 2019 Jan; 12(1):11-15. PubMed ID: 30881571
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.